Table 2.
Occurrence of HLA-C alleles in the nevirapine (NVP)-rash cases and NVP-tolerant controls in Thailand
| Allele | NVP-induced rash number (%) | NVP-tolerant number (%) | *P value |
| HLA-Cw*01 | 12 (15.38) | 12 (10.00) | NS |
| HLA-Cw*03 | 4 (5.13) | 20 (16.67) | 0.01 |
| HLA-Cw*04 | 16 (20.51) | 9 (7.50) | 0.009 |
| HLA-Cw*05 | 2 (2.56) | 3 (2.50) | NS |
| HLA-Cw*06 | 8 (10.26) | 9 (7.50) | NS |
| HLA-Cw*07 | 19 (24.36) | 39 (35.50) | NS |
| HLA-Cw*08 | 9 (11.54) | 15 (12.50) | NS |
| HLA-Cw*12 | 6 (7.69) | 8 (6.67) | NS |
| HLA-Cw*14 | 0 | 3 (2.50) | NS |
| HLA-Cw*15 | 2 (2.56) | 2 (1.67) | NS |
| Total | 78 | 120 | |
*Fisher's exact test
NS: P > 0.05